Tilray Brands TLRY remains a cautious investment, according to Zuanic & Associates, despite its solid balance sheet and diverse global assets. With a "Neutral" rating, Zuanic views Tilray as a long-term player in the cannabis sector, though short-term uncertainties cloud its outlook.
The cannabis industry in the US is on the rise, with legalization efforts moving forward and supporting sector growth. This week, top cannabis REIT stocks, such as Innovative Industrial Properties, AFC Gamma, and NewLake Capital Partners, are in focus as they offer financial support through real estate. Current policies on state ballots could further influence the cannabis market, as several states are voting on legalization measures. These outcomes could impact cannabis stocks significantly, offering opportunities for growth if more states legalize cannabis use. The industry's revenue could reach $50 billion by 2025, making it an attractive sector for investors.
Chicago Atlantic Real Estate Finance, Inc. REFI, a leading commercial mortgage real estate investment trust (REIT), has announced the closure of a $50 million unsecured term loan with two institutional private lending platforms. This funding aims to support the company's future investments and various general corporate purposes.
ACB and MedReleaf Australia launch premium medical cannabis oils, offering tailored cannabinoid formulations for patient care.
The cannabis industry in the US continues to experience rapid growth, with an estimated market size of $32 billion in 2024. This expansion is fueled by increasing state-level legalization and a growing consumer base. Cannabis REITs are emerging as key players, providing real estate and capital to cannabis operators. These REITs offer attractive dividend yields, often exceeding 7%, making them appealing to income-focused investors. Recently, headlines about potential federal legalization have sparked renewed interest in the sector. Investors are keen on capturing both short-term gains and long-term growth opportunities.
The US cannabis industry is experiencing rapid growth, with sales expected to reach $45.8 billion by 2025. Ancillary companies, which support the cannabis sector through technology, supplies, and services, are increasingly crucial for market expansion. Recent headlines indicate that US lawmakers are pushing for federal legalization, sparking optimism across the sector. As the legalization debate intensifies, ancillary companies stand to benefit significantly from industry-wide growth. Investors looking to capitalize on this momentum should watch top-performing ancillary cannabis stocks. These companies provide necessary services that fuel dispensary and cultivation operations, making them essential players in the cannabis ecosystem.
Tilray Brands (TLRY) CEO Irwin D. Simon says the "market didn't recognize" everything highlighted in its earnings report.
Tilray Brands (TLRY) Chief Executive Officer (CEO) Irwin Simon said the 2024 presidential election is likely to improve the legal cannabis industry in the U.S.—regardless of who wins.
The US cannabis industry continues to expand at an impressive pace, with projections estimating it could reach $45 billion in annual sales by 2025. The growth has been fueled by the increasing legalization of both medical and recreational cannabis across states. Recently, headlines have focused on the possibility of federal cannabis legalization, which would be a game-changer for the industry. Investors are closely watching these developments as they could drive significant stock gains. As the industry evolves, keeping an eye on the top-performing cannabis stocks can offer promising investment opportunities.
Marijuana stock investors are focused on investing in the future of the sector. Yes with how volatile the industry can be some days are time to take profits Yet there is still much to be done for the cannabis industry to reach what some are saying is its full potential. Much of this is circulated through better regulations and the passing of federal reform along with fair taxes in each state.
The licenses will add $1.6 million to our total Assets for the 3rd Quarter. AUSTIN, TX / ACCESSWIRE / October 9, 2024 / MedCana (OTC PINK:SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, proudly announces significant and multiple acquisitions, along with multiple cannabis licenses associated with each, bolstering the company's cannabis portfolio globally.
This Canadian pot stock has defied the broader downturn among its peer group in 2024.